Free Trial

Bellerophon Therapeutics (BLPH) Institutional Ownership

→ Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad)
Free BLPH Stock Alerts
$0.06
0.00 (0.00%)
(As of 04/25/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaSustainability

Institutional Ownership Changes (13F Filings) for Bellerophon Therapeutics (NASDAQ:BLPH)

Current
Institutional Ownership
Percentage
10.61%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$183.02K
Number of
Institutional Sellers
(last 12 months)
0
Get BLPH Insider Trade Alerts

Want to know when executives and insiders are buying or selling Bellerophon Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

BLPH Institutional Buying and Selling by Quarter

Bellerophon Therapeutics Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/7/2023Acadian Asset Management LLC265,253$182K0.0%N/A2.538%
11/17/2022Telemetry Investments L.L.C.47,500$52K0.1%-31.2%0.497%
7/26/2022Sepio Capital LP23,800$29K0.0%N/A0.249%
11/16/2021Telemetry Investments L.L.C.85,500$347K0.5%-6.0%0.899%
11/12/2021Renaissance Technologies LLC201,706$819K0.0%-21.5%2.122%
11/9/2021BlackRock Inc.120,620$490K0.0%+3.6%1.268%
9/17/2021Virtu Financial LLC16,495$80K0.0%N/A0.174%
8/16/2021Telemetry Investments L.L.C.90,920$440K0.6%+48.9%0.956%
8/16/2021State Street Corp21,027$102K0.0%-63.1%0.221%
8/13/2021Renaissance Technologies LLC257,072$1.24M0.0%+10.0%2.704%
8/13/2021Northern Trust Corp36,555$177K0.0%-51.6%0.385%
8/13/2021Geode Capital Management LLC58,380$282K0.0%-8.0%0.614%
8/13/2021Vanguard Group Inc.336,966$1.63M0.0%-6.2%3.545%
8/12/2021JPMorgan Chase & Co.6,507$31K0.0%+242.5%0.068%
8/12/2021Ergoteles LLC13,800$67K0.0%N/A0.145%
5/21/2021Citadel Advisors LLC20,000$104K0.0%N/A0.210%
5/19/2021Squarepoint Ops LLC14,569$76K0.0%N/A0.153%
5/18/2021New Mountain Vantage Advisers L.L.C.252,650$3.16M0.1%-75.0%2.658%
5/18/2021Tudor Investment Corp Et Al20,000$104K0.0%N/A0.210%
5/18/2021Citadel Advisors LLC20,000$104K0.0%N/A0.210%
5/17/2021Caas Capital Management LP97,900$508K0.0%N/A1.030%
5/14/2021Laurion Capital Management LP20,000$104K0.0%N/A0.210%
5/13/2021Renaissance Technologies LLC233,799$1.21M0.0%+9.1%2.459%
5/12/2021Northern Trust Corp75,579$393K0.0%-15.7%0.795%
5/11/2021Element Capital Management LLC11,646$60K0.0%N/A0.123%
5/10/2021GSA Capital Partners LLP63,566$330K0.1%+6.7%0.669%
5/7/2021BlackRock Inc.321,782$1.67M0.0%+2.3%3.385%
4/28/2021DAVENPORT & Co LLC98,975$514K0.0%+10.9%1.041%
2/19/2021JPMorgan Chase & Co.10,701$72K0.0%+261.4%0.113%
2/12/2021LPL Financial LLC10,080$67K0.0%N/A0.106%
2/11/2021Northern Trust Corp89,607$598K0.0%-2.8%0.943%
2/10/2021Renaissance Technologies LLC214,299$1.43M0.0%-13.7%2.256%
2/9/2021Wells Fargo & Company MN202,330$1.35M0.0%+83.5%2.130%
2/5/2021BlackRock Inc.314,617$2.10M0.0%+9.8%3.312%
2/4/2021GSA Capital Partners LLP59,589$397K0.1%+112.1%0.627%
11/16/2020AQR Capital Management LLC34,071$347K0.0%N/A0.359%
11/10/2020State Street Corp59,077$601K0.0%+82.9%0.622%
11/6/2020GSA Capital Partners LLP28,092$286K0.0%N/A0.296%
11/5/2020First Trust Advisors LP20,415$208K0.0%N/A0.215%
11/5/2020Wells Fargo & Company MN110,236$1.12M0.0%+6,163.4%1.161%
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>
10/30/2020WINTON GROUP Ltd12,498$127K0.0%N/A0.132%
10/15/2020DAVENPORT & Co LLC94,475$962K0.0%-11.8%0.994%
8/25/2020Nuveen Asset Management LLC21,592$271K0.0%N/A0.227%
8/20/2020Charles Schwab Investment Management Inc.11,586$146K0.0%N/A0.122%
8/14/2020Bank of America Corp DE6,501$82K0.0%+49,907.7%0.068%
8/14/2020Telemetry Investments L.L.C.125,000$1.57M4.3%+150.0%1.316%
8/12/2020American International Group Inc.2,105$26K0.0%N/A0.022%
8/12/2020Tocqueville Asset Management L.P.25,400$319K0.0%+124.8%0.267%
8/7/2020New York State Common Retirement Fund8,000$100K0.0%N/A0.084%
7/28/2020DAVENPORT & Co LLC107,150$1.35M0.0%N/A1.128%
6/24/2020New Mountain Vantage Advisers L.L.C.100,231$16.92M0.9%-99.3%1.635%
5/15/2020Morgan Stanley2,633$29K0.0%+426.6%0.043%
5/15/2020Telemetry Investments L.L.C.50,000$548K1.9%-85.2%0.815%
5/15/2020New Mountain Vantage Advisers L.L.C.100,231$16.92M0.9%-99.3%1.635%
5/14/2020Credit Agricole S A3,160$35K0.0%N/A0.052%
(Data available from 1/1/2016 forward)

BLPH Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of BLPH shares?

During the previous two years, the following institutional investors and hedge funds held shares of Bellerophon Therapeutics shares: Acadian Asset Management LLC ($182K), and Telemetry Investments L.L.C. ($52K), Sepio Capital LP ($29K).Learn more on BLPH's institutional investors.

What percentage of Bellerophon Therapeutics stock is owned by institutional investors?

10.61% of Bellerophon Therapeutics stock is owned by institutional investors. Learn more on BLPH's institutional investor holdings.

Which institutional investors have been buying Bellerophon Therapeutics stock?

The following institutional investors have purchased Bellerophon Therapeutics stock in the last 24 months: Acadian Asset Management LLC ($265.25K), and Sepio Capital LP ($23.80K).

How much institutional buying is happening at Bellerophon Therapeutics?

Institutional investors have bought a total of 289,053 shares in the last 24 months. This purchase volume represents approximately $212.30K in transactions.

Which Bellerophon Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Bellerophon Therapeutics stock in the last 24 months: Telemetry Investments L.L.C. ($21.50K).

How much institutional selling is happening at Bellerophon Therapeutics?

Institutional investors have sold a total of 21,500 shares in the last 24 months. This volume of shares sold represents approximately $23.44K in transactions.


Related Companies:
This page (NASDAQ:BLPH) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners
These AI trades triggered this morning (545% return)
Prosper Trading Academy
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
He Is Giving Away Bitcoin
Crypto Swap Profits
Jim Cramer’s “The Biggest Drug Ever”
Behind the Markets
Your Money is Not Safe
American Alternative
The AI stock to buy right now
StockEarnings
The only accurate crypto trading system I know …
Weiss Ratings